Search


Current filters:

Start a new search
Add filters:

Use filters to refine the search results.


Results 1-10 of 10 (Search time: 0.003 seconds).
  • previous
  • 1
  • next
Item hits:
PreviewIssue DateTitleAuthor(s)
2018Testosterone for type 2 diabetes prevention in men: A 2-year multicentre, randomised, double-blind, placebo-controlled trialWittert, G.; Atlantis, E.; Grossmann, M.; Yeap, B.B.; Conway, A.; Stuckey, B.; Handelsman, D.; McLachlan, R.; Allan, C.; Jenkins, A.; Daniel, M.; Bracken, K.; The Joint Annual Scientific Meetings of the Endocrine Society of Australia and the Society for Reproductive Biology (ESA-SRB 2017) (27 Aug 2017 - 30 Aug 2017 : Perth, AUSTRALIA)
2019A high-volume, low-cost approach to participant screening and enrolment: experiences from the T4DM diabetes prevention trialBracken, K.; Keech, A.; Hague, W.; Allan, C.; Conway, A.; Daniel, M.; Gebski, V.; Grossmann, M.; Handelsman, D.J.; Inder, W.J.; Jenkins, A.; McLachlan, R.; Robledo, K.P.; Stuckey, B.; Yeap, B.B.; Wittert, G.
2019Recruitment of men to a multi-centre diabetes prevention trial: an evaluation of traditional and online promotional strategiesBracken, K.; Hague, W.; Keech, A.; Conway, A.; Handelsman, D.J.; Grossmann, M.; Jesudason, D.; Stuckey, B.; Yeap, B.B.; Inder, W.; Allan, C.; McLachlan, R.; Robledo, K.P.; Wittert, G.
2021Testosterone treatment to prevent or revert type 2 diabetes in men enrolled in a lifestyle programme (T4DM): a randomised, double-blind, placebo-controlled, 2-year, phase 3b trialWittert, G.; Bracken, K.; Robledo, K.P.; Grossmann, M.; Yeap, B.B.; Handelsman, D.J.; Stuckey, B.; Conway, A.; Inder, W.; McLachlan, R.; Allan, C.; Jesudason, D.; Fui, M.N.T.; Hague, W.; Jenkins, A.; Daniel, M.; Gebski, V.; Keech, A.
2019Testosterone therapy to prevent type 2 diabetes mellitus in at-risk men (T4DM): design and implementation of a double-blind randomized controlled trialWittert, G.; Atlantis, E.; Allan, C.; Bracken, K.; Conway, A.; Daniel, M.; Gebski, V.; Grossmann, M.; Hague, W.; Handelsman, D.J.; Inder, W.; Jenkins, A.; Keech, A.; McLachlan, R.; Robledo, K.; Stuckey, B.; Yeap, B.B.
2016High circulating oestrone and low testosterone correlate with adverse clinical outcomes in men with advanced liver diseaseSinclair, M.; Gow, P.J.; Angus, P.W.; Hoermann, R.; Handelsman, D.J.; Wittert, G.; Martin, S.; Grossmann, M.
2015Effects of testosterone treatment on glucose metabolism and symptoms in men with type 2 diabetes and the metabolic syndrome: a systematic review and meta-analysis of randomized controlled clinical trialsGrossmann, M.; Hoermann, R.; Wittert, G.; Yeap, B.
2023Mediation analysis of the testosterone treatment effect to prevent type 2 diabetes in the Testosterone for Prevention of Type 2 Diabetes Mellitus trialRobledo, K.P.; Marschner, I.C.; Handelsman, D.J.; Bracken, K.; Stuckey, B.G.A.; Yeap, B.B.; Inder, W.; Grossmann, M.; Jesudason, D.; Allan, C.A.; Wittert, G.
2019Telephone call reminders did not increase screening uptake more than SMS reminders: a recruitment study within a trialBracken, K.; Keech, A.; Hague, W.; Kirby, A.; Robledo, K.P.; Allan, C.; Conway, A.; Daniel, M.; Gebski, V.; Grossmann, M.; Handelsman, D.J.; Inder, W.; Jenkins, A.; McLachlan, R.; Stuckey, B.; Yeap, B.B.; Wittert, G.
2012Androgens, diabetes and prostate cancerGrossmann, M.; Wittert, G.